Healthpeak Properties (NYSE:DOC) Upgraded at Morgan Stanley

Morgan Stanley upgraded shares of Healthpeak Properties (NYSE:DOCFree Report) from an equal weight rating to an overweight rating in a research report report published on Wednesday morning, Marketbeat reports. Morgan Stanley currently has $25.00 price objective on the real estate investment trust’s stock.

Several other analysts have also weighed in on the company. Deutsche Bank Aktiengesellschaft upgraded Healthpeak Properties from a “hold” rating to a “buy” rating and increased their price target for the company from $20.00 to $28.00 in a report on Monday, October 21st. Mizuho decreased their target price on Healthpeak Properties from $25.00 to $24.00 and set an “outperform” rating for the company in a research report on Thursday, December 5th. Robert W. Baird upped their target price on Healthpeak Properties from $24.00 to $25.00 and gave the stock an “outperform” rating in a report on Wednesday, October 30th. Wells Fargo & Company lowered their target price on shares of Healthpeak Properties from $23.00 to $22.00 and set an “equal weight” rating for the company in a research note on Tuesday, December 10th. Finally, Royal Bank of Canada increased their price objective on shares of Healthpeak Properties from $25.00 to $26.00 and gave the company an “outperform” rating in a research report on Monday, November 4th. One investment analyst has rated the stock with a sell rating, three have given a hold rating, ten have given a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $24.15.

Check Out Our Latest Stock Report on DOC

Healthpeak Properties Price Performance

NYSE DOC opened at $20.80 on Wednesday. The company has a quick ratio of 1.31, a current ratio of 1.31 and a debt-to-equity ratio of 0.93. The firm has a market capitalization of $14.55 billion, a P/E ratio of 44.26, a PEG ratio of 2.12 and a beta of 1.14. Healthpeak Properties has a 52 week low of $16.01 and a 52 week high of $23.26. The company has a 50-day moving average price of $20.90 and a 200-day moving average price of $21.49.

Healthpeak Properties (NYSE:DOCGet Free Report) last announced its quarterly earnings results on Thursday, October 24th. The real estate investment trust reported $0.12 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.44 by ($0.32). The company had revenue of $700.40 million during the quarter, compared to the consensus estimate of $682.51 million. Healthpeak Properties had a net margin of 12.10% and a return on equity of 3.53%. The business’s revenue was up 25.9% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.45 earnings per share. Equities research analysts anticipate that Healthpeak Properties will post 1.81 earnings per share for the current year.

Healthpeak Properties Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, November 15th. Shareholders of record on Monday, November 4th were issued a $0.30 dividend. The ex-dividend date was Monday, November 4th. This represents a $1.20 dividend on an annualized basis and a yield of 5.77%. Healthpeak Properties’s payout ratio is 255.32%.

Institutional Investors Weigh In On Healthpeak Properties

Hedge funds have recently modified their holdings of the company. State Street Corp purchased a new position in Healthpeak Properties during the third quarter valued at $1,093,576,000. Geode Capital Management LLC acquired a new stake in shares of Healthpeak Properties in the third quarter worth approximately $403,898,000. Charles Schwab Investment Management Inc. acquired a new position in Healthpeak Properties during the third quarter worth about $230,988,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC purchased a new position in Healthpeak Properties during the third quarter worth approximately $175,697,000. Finally, Sumitomo Mitsui Trust Group Inc. purchased a new stake in Healthpeak Properties in the 3rd quarter valued at $102,615,000. 93.57% of the stock is owned by hedge funds and other institutional investors.

Healthpeak Properties Company Profile

(Get Free Report)

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.

Featured Stories

Analyst Recommendations for Healthpeak Properties (NYSE:DOC)

Receive News & Ratings for Healthpeak Properties Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthpeak Properties and related companies with MarketBeat.com's FREE daily email newsletter.